Effects of a 10 Component Dietary Supplement on Health and the Quality of Life

Completed · Not applicable · Has a placebo group

Conditions studied: Blood Pressure, HDL Low, Stress, Lung Function Decreased, Quality of Life, Energy Supply; Deficiency, Concentration Ability Impaired, Joint Instability, Immune Deficiency

In brief

This open-label field trial evaluates the effects of treatment with a multi-pathway dietary supplement (Stem Cell 100+) that has been commercially available for several years. The objective of the intervention trial is to determine if normal subjects over 35 years of age experience any observable health benefits from the dietary supplement as to their blood pressure, pulse rate, blood cholesterol, lung capacity, stress levels, or self reported changes in markers of overall health and life expectancy.

Key facts

Study ID

NCT03052491

Run by

Centagen, Inc.

People needed

15

Starts

2016-03-12

Expected to finish

2016-08-24

Last updated by the study team

2017-02-14

Who can join

Age: 35 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No history of serious cardiovascular, cancer, or neural disease.
• Normal health for age
• Willing to have blood drawn at baseline and after trial
• Willing to submit to evaluation testing of blood pressure, lung testing, stress testing.
• Willing to take online self reported survey of health at end of trial

You may not qualify if…

• History of metastatic cancer, heart attack, dementia, or other life-threatening disease
• Any subject who is not capable of responding to a self-reported online questionnaire
• Pregnant

Where it is running

• Accelagen, Inc. — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.